Anticoagulation clinics in an integrated healthcare system differed widely in their organization and management, but these differences were not consistently related to their performance. To describe ...
The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with atrial fibrillation after two years of treatment, according to ...
Atrial fibrillation (AF), which affects approximately 3-6 million people in the United States, is a risk factor for thromboembolic events including stroke, cardiovascular events, and death. This ...
Warfarin is the cornerstone of venous thromboembolism (VTE) treatment. An appropriate international normalized ratio (INR) range of prothrombin time can prevent recurrent VTE and decrease bleeding ...
For decades now, stroke prevention in patients with atrial fibrillation has largely consisted of chronic oral anticoagulation, often with no end in sight. But a growing number of experts are asking: ...
SAN FRANCISCO, CA—Oral anticoagulation following transcatheter aortic valve replacement fails to lower the incidence of new subclinical cerebral lesions identified on imaging when compared with dual ...
High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results